Unpaid work in health economic evaluations

被引:43
作者
Krol, Marieke [1 ,2 ]
Brouwer, Werner [1 ,2 ]
机构
[1] Erasmus Univ, Dept Hlth Policy & Management, Rotterdam, Netherlands
[2] Erasmus Univ, Inst Med Technol, Rotterdam, Netherlands
关键词
Productivity costs; Unpaid work; Economic evaluation; Perspective Health economic guidelines; Rheumatoid arthritis; Review; SEVERE RHEUMATOID-ARTHRITIS; COST-UTILITY ANALYSIS; QUALITY-OF-LIFE; PRODUCTIVITY COSTS; TREATMENT STRATEGIES; STATE VALUATIONS; INFORMAL CARE; SOCIETAL PERSPECTIVE; INADEQUATE RESPONSE; LOST-PRODUCTIVITY;
D O I
10.1016/j.socscimed.2015.09.008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Given its societal importance, unpaid work should be included in economic evaluations of health care technology aiming to take a societal perspective. However, in practice this does not often appear to be the case. This paper provides an overview of the current place of unpaid work in economic evaluations in theory and in practice. It does so first by summarizing recommendations regarding the inclusion of unpaid labor reported in health economic textbooks and national guidelines for economic evaluations. In total, three prominent health economic text-books were studied and 28 national health economic guidelines. The paper, moreover, provides an overview of the instruments available to measure lost unpaid labor and reports on a review of the place of unpaid labor in applied economic evaluations in the area of rheumatoid arthritis. The review was conducted by examining methodology of evaluations published between 1 March 2008 and 1 March 2013. The results of this study show that little guidance is offered regarding the inclusion of unpaid labor in economic evaluations in textbooks and guidelines. The review identified five productivity costs instruments including questions about unpaid work and 33 economic evaluations of treatments for rheumatoid arthritis of which only one included unpaid work. The results indicate that unpaid work is rarely included in applied economic evaluations of treatments for rheumatoid arthritis, despite this disease expecting to be associated with lost unpaid work. Given the strong effects of certain diseases and treatments on the ability to perform unpaid work, unpaid work currently receives less attention in economic evaluations than it deserves. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 137
页数:11
相关论文
共 89 条
[1]   Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in The Netherlands [J].
Al, Maiwenn J. ;
Maniadakis, Nikos ;
Grijseels, Els W. M. ;
Janssen, Matthijs .
VALUE IN HEALTH, 2008, 11 (04) :589-599
[2]  
[Anonymous], 2002, Methods for The Economic Evaluation of Health Care Programmes
[3]  
[Anonymous], 1999, MED DECIS MAK
[4]  
[Anonymous], 54 U YORK CTR HLTH E
[5]   Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life [J].
Benucci, Maurizio ;
Saviola, Gianantonio ;
Baiardi, Paola ;
Manfredi, Mariangela .
RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) :1465-1469
[6]   Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain [J].
Beresniak, Ariel ;
Ariza-Ariza, Rafael ;
Francisco Garcia-Llorente, Jose ;
Ramirez-Arellano, Antonio ;
Dupont, Danielle .
INTERNATIONAL JOURNAL OF INFLAMMATION, 2011, 2011
[7]  
Bessette Louis, 2009, J Med Econ, V12, P246, DOI 10.3111/13696990903288970
[8]  
Bouwmans C, 2013, iMTA Medical Consumption Questionnaire
[9]  
Brouwer WBF, 1997, HEALTH ECON, V6, P253, DOI 10.1002/(SICI)1099-1050(199705)6:3<253::AID-HEC266>3.3.CO
[10]  
2-Y